Transform lives

  • Build strategy
  • Generate evidence
  • Communicate value


Life Science Consulting - From Bench to Bed

ABOUT 

Life Science Consulting - Pharmaceuticals, Biotechnology & Medical Device

YM-MEDICAL provides expert advice to pharmaceutical, biotech, and medical device companies, including start-ups and life science investors.


YM-MEDICAL provide advice by combining a deep understanding of the basic sciences, non-clinical/clinical R&D, regulatory context, clinical medicine, and health economics, coupled with solid business consulting.

Dr. Yngve Mikkelsen

CEO

EXPERIENCE

15+ years of clinical development and medical affairs experience from Big-Pharma, Bio-tech, Med-tech and the CRO industry covering therapeutic areas such as oncology, neurology and immunology. 20+ years of management experience as executive VP, CMO and from senior management roles in healthcare and industry. Specialises in clinical development and business strategies, including real-world evidence, market access and health economics.


EDUCATION

Yngve Mikkelsen, MD, is a clinical specialist in anaesthesiology and holds a Master of Management (MM) degree from the Norwegian Business School, a Doctorate of Business Administration (DBA) from Cranfield University and a Master of Science (MSc) in health economics, policy and management from the London School of Economics.


CORE SKILLS

  • Clinical Development
  • Market Access and Health Economics
  • Real-World Evidence
  • Pharmacovigilance
  • Business strategies/development
  • Market analytics
  • Management
  • Medical Affairs
  • Anaesthesia/Pain/Respiratory
  • Neurology/Immunology
  • Oncology/Infectious diseases
    • Dermatology/Ophthalmology

    Services

    Strategy development

    Identifying the optimal connection between products and market with a focus on:

    • Burden of illness evaluation
    • Treatment pathway and guidelines assessment
    • Competitor pricing, reimbursement and HTA review
    • Current and future policy assessment
    • Market sizing and revenue forecasting
    • Early product assessment
    • Positioning and launch strategy
    • Health Economics and Outcomes Research (HEOR) strategy
    • Parallel consultation with regulators and HTA bodies (EMA)

    Evidence generation

    Evidence generation essential for market access and price optimization with a focus on:

    • Trial and endpoint optimization
    • Pricing/Willingness-to-pay
    • Comparative / real-world safety evaluation
    • Comparative / real-world effectiveness evaluation
    • Patient-reported outcome (PRO) assessment
    • Utilization/cost
    • Preference/adherence
    • Health economic assessment

    Value proposition development

    Communicating product value in the marketplace by focusing on:

    • Health economic and market access training
    • Value dossiers / monographs
    • Value communication tools/toolkits
    • Slide decks
    • Medical education and training
    • Disease awareness
    • Publication planning and support
    • Reimbursement / HTA submissions
    • Regulatory dossiers
    • Policy and regulatory support

    Value communication

    Business development

    Build a path to your future by focusing on:

    • Commercial strategy development
    • Market analytics
    • Competitive landscape
    • Stakeholder identification and evaluation
    • Communication strategy
    • Partnering
    • Licencing
    • Negotiation
    • Fundraising

    CONTACTS

    Dr. Yngve Mikkelsen